Polyactiva

Polyactiva company information, Employees & Contact Information

Explore related pages

Related company profiles:

PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to the eye. With the PolyActiva technology, exceptional zero-order release profiles are achieved over treatment periods ranging from 6 to 12 months. Our mission is to become a leader in ophthalmic medicine by providing unique biodegradable implants with sustained drug delivery to improve patient outcomes and quality of life.

Company Details

Employees
25
Founded
-
Address
Collins Street, Melbourne,vic,australia
Phone
61 3 9657 0700
Email
in****@****iva.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Melbourne, VIC
Looking for a particular Polyactiva employee's phone or email?

Polyactiva Questions

News

PolyActiva secures $40 million AUD in Series C funding - Ophthalmology Times

PolyActiva secures $40 million AUD in Series C funding Ophthalmology Times

PolyActiva Expands Executive Team to Drive Transformational Growth and Advance Late-Stage Clinical Development in the U.S. - Business Wire

PolyActiva Expands Executive Team to Drive Transformational Growth and Advance Late-Stage Clinical Development in the U.S. Business Wire

PolyActiva Appoints Jerry St. Peter as CEO and Secures $25M Series C Financing to Accelerate US Expansion and Clinical Advancement of PREZIA™ Technology Platform - Business Wire

PolyActiva Appoints Jerry St. Peter as CEO and Secures $25M Series C Financing to Accelerate US Expansion and Clinical Advancement of PREZIA™ Technology Platform Business Wire

Australia’s PolyActiva Opens Fort Worth Office With New Locally Based CEO, CFO, and CSO - Dallas Innovates

Australia’s PolyActiva Opens Fort Worth Office With New Locally Based CEO, CFO, and CSO Dallas Innovates

Australia's PolyActiva secures AUD $40M in Series C to advance ocular drug delivery - BioSpectrum Asia

Australia's PolyActiva secures AUD $40M in Series C to advance ocular drug delivery BioSpectrum Asia

Labor takes $27m stake in breakthrough eye biotech - AFR

Labor takes $27m stake in breakthrough eye biotech AFR

PolyActiva’s PA5108 glaucoma implant shows promising results in clinical trial, paving the way for long-term drug delivery - Ophthalmology Times

PolyActiva’s PA5108 glaucoma implant shows promising results in clinical trial, paving the way for long-term drug delivery Ophthalmology Times

PolyActiva makes ‘significant’ step in glaucoma drug delivery implant - insightnews.com.au

PolyActiva makes ‘significant’ step in glaucoma drug delivery implant insightnews.com.au

PolyActiva to Present Advancements in Next-Generation Ocular Micro-Implant Technology at Eyecelerator® @ AAO 2025 - Business Wire

PolyActiva to Present Advancements in Next-Generation Ocular Micro-Implant Technology at Eyecelerator® @ AAO 2025 Business Wire

Intra-articular Treatment of Osteoarthritis with Diclofenac-Conjugated Polymer Reduces Inflammation and Pain - ACS Publications

Intra-articular Treatment of Osteoarthritis with Diclofenac-Conjugated Polymer Reduces Inflammation and Pain ACS Publications

Top Polyactiva Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant